| Dr Lisa Veva Thomassen, MD | |
|
1280 116th Ave Ne, Suite 210, Bellevue, WA 98004-3803 | |
| (425) 646-0922 | |
| (425) 646-0925 |
| Full Name | Dr Lisa Veva Thomassen |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 32 Years |
| Location | 1280 116th Ave Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568426955 | NPI | - | NPPES |
| 8212615 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD00033985 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
Benefitfocus today unveiled its Medical Loss Ratio Rebate App, which helps health insurance companies calculate premium contributions and manage rebates as they adjust to new medical loss ratio (MLR) requirements.
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.
The U.S. Food and Drug Administration today approved Botox injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.
CVS Health today announced the launch of ScriptSync, a new pharmacy service that enables patients with multiple medications to pick up their eligible maintenance prescriptions in a monthly CVS/pharmacy visit.
› Verified 1 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Benefitfocus today unveiled its Medical Loss Ratio Rebate App, which helps health insurance companies calculate premium contributions and manage rebates as they adjust to new medical loss ratio (MLR) requirements.
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.
The U.S. Food and Drug Administration today approved Botox injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.
CVS Health today announced the launch of ScriptSync, a new pharmacy service that enables patients with multiple medications to pick up their eligible maintenance prescriptions in a monthly CVS/pharmacy visit.
› Verified 1 days ago
| Entity Name | The Polyclinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174594634 PECOS PAC ID: 2163328196 Enrollment ID: O20031210000788 |
News Archive
Benefitfocus today unveiled its Medical Loss Ratio Rebate App, which helps health insurance companies calculate premium contributions and manage rebates as they adjust to new medical loss ratio (MLR) requirements.
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.
The U.S. Food and Drug Administration today approved Botox injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.
CVS Health today announced the launch of ScriptSync, a new pharmacy service that enables patients with multiple medications to pick up their eligible maintenance prescriptions in a monthly CVS/pharmacy visit.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lisa Veva Thomassen, MD Po Box 100559, Florence, SC 29501-0559 Ph: (843) 664-4300 | Dr Lisa Veva Thomassen, MD 1280 116th Ave Ne, Suite 210, Bellevue, WA 98004-3803 Ph: (425) 646-0922 |
News Archive
Benefitfocus today unveiled its Medical Loss Ratio Rebate App, which helps health insurance companies calculate premium contributions and manage rebates as they adjust to new medical loss ratio (MLR) requirements.
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.
The U.S. Food and Drug Administration today approved Botox injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.
CVS Health today announced the launch of ScriptSync, a new pharmacy service that enables patients with multiple medications to pick up their eligible maintenance prescriptions in a monthly CVS/pharmacy visit.
› Verified 1 days ago
Dr. David Denton Nordin, MD Pathology Medicare: Medicare Enrolled Practice Location: 1280 116th Ave Ne, Ste. 210, Bellevue, WA 98004 Phone: 425-646-0922 Fax: 425-646-0925 | |
Dr. Stephen John Sarewitz, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1280 116th Ave Ne, Suite 210, Bellevue, WA 98004 Phone: 425-646-0922 Fax: 425-646-0925 | |
Dr. Richard James Huehnergarth, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1280 116th Ave Ne, Suite 210, Bellevue, WA 98004 Phone: 425-646-0922 Fax: 425-646-0925 | |
Dr. Archimedes D Garbes, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1280 116th Ave Ne, Suite 210, Bellevue, WA 98004 Phone: 425-646-0922 Fax: 425-646-0925 | |
Dr. Sandra Pauline Ewaskow, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1280 116th Ave Ne, Suite 210, Bellevue, WA 98004 Phone: 425-646-0922 Fax: 425-646-0925 | |
Dr. Robert Farrell Kapela, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5652 132nd Ave Ne, Bellevue, WA 98005 Phone: 425-885-7996 | |
Dr. Peter A Herreid, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1280 116th Ave Ne, Suite 210, Bellevue, WA 98004 Phone: 425-646-0922 Fax: 425-646-0925 |